In the case of Ozempic and Wegovy, compounding pharmacies have developed alternatives as a response to the shortage of these drugs
Before starting any GLP-1 program in 2026, patients are encouraged to ask their prescribing clinician and the dispensing pharmacy specific questions about dosing, proper storage, potential adverse reactions, drug interactions, current product availability, and whether an FDA-approved medication may be more appropriate for their individual situation
& Nilges, M
Ozempic and the broader family of GLP-1 medications appear to lower inflammation directly
Instead, they often include herbal extracts, vitamins, or other compounds claimed to "support" GLP-1 production or function
Diabet Med 10:4449 Acknowledgements We thank K